Clinical trial Recruiting at 1 site Observational Ages 45 to 54

Colorectal cancer screening for unscreened people aged 45–54

Official title: Initiating Colorectal Cancer Screening in Unscreened Individuals 45 to 54

Run by Massachusetts General Hospital · NCT06757192 · Data updated 2026-11-12

This project will try to find what helps or gets in the way of colorectal cancer screening for patients aged 45–54 at community health centers by talking with patients and staff and linking staff survey results to clinic records.

More Colorectal Cancer Screening trials

Quick facts

Study typeObservational
Ages45 Years to 54 Years
SexAll
Enrollment40 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJune 16, 2025
Main results expectedAugust 31, 2029
Study endsAugust 31, 2029
Registry record updatedNovember 13, 2025
Trial IDNCT06757192 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 45–54 who receive care at the participating community health centers, have not completed colorectal cancer screening, and can give verbal or written consent.

Probably not a fit

People with a personal or family history of colorectal cancer, inflammatory bowel disease, high-risk cancer syndromes, or those who have already completed screening are excluded and are unlikely to benefit from this observational work.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, mixed-methods project uses the CFIR implementation framework to identify system-level determinants of colorectal cancer screening in unscreened patients aged 45–54. The team will conduct a validated organizational survey with staff and providers at Codman Square Health Center and nine partner community health centers and link those survey responses to patient-level electronic health record data. Researchers will also do one-time in-depth interviews with patient-facing community health center staff, providers, and patients, with interviews conducted online or in person. Findings will be used to map barriers and facilitators within clinic systems that influence screening completion.

Why it matters

Potential benefit: If successful, the findings could help clinics change processes to increase screening rates and detect colorectal cancer earlier in people aged 45–54.

How similar studies have gone: Previous implementation and CFIR-based studies have identified clinic-level barriers to screening and supported targeted improvements in some settings, so the approach has precedent.

Who can join: the full rules

Show full inclusion / exclusion criteria
PATIENTS

Inclusion Criteria:

* Individuals aged 45-54
* Individuals who are patients at the health center
* Individuals that are willing and able to give verbal/written consent

Exclusion Criteria:

* Individuals with a personal history of CRC
* Individuals with a family history of CRC
* Individuals with a history of inflammatory bowel disease or high-risk cancer syndrome

STAFF

Inclusion Criteria:

* Individuals ages 18+
* Individuals working at the health center
* Individuals that are involved in CRC screening processes at CSHC
* Individuals that are willing and able to give verbal/written consent

Where it's running

  • Codman Square Health Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.